Mapping of a protective epitope of the CopB outer membrane protein of Moraxella catarrhalis

Infection and Immunity

Volumn 66, Issue 2, 1998, Pages 540-548

  Aebi, Christoph ^a   Cope, Leslie D ^a   Latimer, Jo L ^a   Thomas, Sharon E ^a   Slaughter, Clive A ^a   McCracken Jr , George H ^a   Hansen, Eric J ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY;

AMINO ACID SEQUENCE; ANTIBODY RESPONSE; ANTIGEN EXPRESSION; ARTICLE; BACTERICIDAL ACTIVITY; CELL PROTECTION; ENHANCER REGION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; MORAXELLA CATARRHALIS; NONHUMAN; NUCLEOTIDE SEQUENCE; OUTER MEMBRANE; PRIORITY JOURNAL; PROTEIN ANALYSIS;

EID: 0031882796     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.66.2.540-548.1998     Document Type: Article

References (48)

1. Anonymous. 1089. Consensus. Pediatr. Infect, Dis. J. 8:S94-S97.
2. 1a.Aebi, C., L. D. Cope, J. L. Latimer, S. E. Thomas, C. A. Slaughter, G. H. McCracken, and E. J. Hansen. 1996. Moraxella catarrhalis outer membrane protein CopB: identification of a peptide that contains a protective epitope, abstr. 783, p. 158. In Abstracts of the 36th International Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
3. Aebi, C., B. Stone, M. Beucher, L. D. Cope, I. Maciver, S. E. Thomas, G. H. McCrucken, Jr., P. F. Sparling, and E. J. Hansen. 1996. Expression of the CopB outer membrane protein by Moraxella catarrhalis is regulated by iron and affects iron acquisition from transferrin and lactoferrin. Infect. Immun. 64:2024-2030.
4. Aspin, M. M., A. Hoberman, J. McCarty, S. E. McLinn, S. Aronoff, D. J. Lang, and A. Arrieta. 1995. Comparative study of the safety and efficacy of clarithromycin and amoxicillin-clavulanate in the treatment of acute otitis media in children. J. Pediatr. 126:677-678.
5. Bartos, L. C., and T. F. Murphy. 1988. Comparison of the outer membrane proteins of 50 strains of Branhamella catarrhalis. J. Infect. Dis. 158:761-765.
6. Campagnari, A. A., K. L. Shanks, and D.W. Dyer. 1994. Growth of Moraxella catarrhalis with human transferrin and lactoferrin: expression of iron-repressible proteins without siderophore production. Infect. Immun. 62:4909-4914.
7. Chapman, A. J., Jr., D. M. Musher, S. Jonsson, J. E. Clarridge, and R. J. Wallace, Jr. 1985. Development of bacterial antibody during Branhamella catarrhalis infection. J. Infect. Dis. 151:878-882.
8. Chen, D., J. C. McMichael, K. R. van der Meid, D. Hahn, T. Mininni, J. Cowell, and J. Eldridge. 1996. Evaluation of purified UspA from Moraxella catarrhalis as a vaccine in a murine model after active immunization. Infect. Immun. 64:1900-1905.
9. Chi, D. S., A. Verghese, C. Moore, F. Hamati, and S. L. Berk. 1990. Antibody response to P-protein in patients with Branhamella catarrhalis infections. Am. J. Med. 88(5A):25S-27S.
10. Chou, P. Y., and G. D. Fasman. 1978. Prediction of the secondary structure of proteins from their amino acid sequence. Adv. Enzymol. 47:45-148.
11. Davies, B. I., and F. P. V. Maesen. 1988. The epidemiology of respiratory tract pathogens in Southern Netherlands. Eur. Respir. J. 1:415-420.
12. Del Beccaro, M. A., P. M. Mendelman, A. F. Inglis, M. A. Richardson, N. O. Duncan, C. R. Clausen, and T. L. Stull. 1992. Bacteriology of acute otitis media: a new perspective. J. Pediatr. 120:81-84.
13. Doern, G. V., M. J. Miller, and R. E. Winn. 1981. Branhamella (Neisseria) catarrhalis systemic disease in humans. Arch. Intern. Med. 141:1690-1692.
14. Duim, B., L. van Alphen, P. P. Eijk, H. M. Jansen, and J. Dankert. 1994. Antigenic drift of non-encapsulated Haemophilus influenzae major outer membrane protein P2 in patients with chronic bronchitis is caused by point mutations. Mol. Microbiol. 11:1181-1189.
15. Duim, B., L. Vogel, W. Puijk, H. M. Jansen, R. H. Meloen, J. Dankert, and L. van Alphen. 1996. Fine mapping of outer membrane protein P2 antigenic sites which vary during persistent infection by Haemophilus influenzae. Infect. Immun. 64:4673-4679.
16. Ey, P. I., S. J. Prowse, and C. R. Jenkin. 1978. Isolation of pure IgG1, IgG2a, and IgG2b immunoglobulins from mouse serum using protein A-sepharose. Immunochemistry 15:429-436.
17. Faden, H., J. J. Hong, and N. Pahade. 1994. Immune response to Moraxella catarrhalis in children with otitis media: opsonophagocytosis with antigencoated latex beads. Ann. Otol. Rhinol. Laryngol. 103:522-524.
18. Faden, H. S., J. J. Hong, and T. F. Murphy, 1992. Immune response to outer membrane antigens of Moraxella catarrhalis in children with otitis media. Infect. Immun. 60:3824-3829.
19. Gan, V. N., H. Kusmiesz, S. Shelton, and J. D. Nelson. 1991. Comparative evaluation of loracarbef and amoxicillin-clavulanate for acute otitis media. Antimicrob. Agents Chemother. 35:967-971.
20. Goldblatt, D., N. D. Seymour, R. J. Levinsky, and M. W. Turner, 1990. An enzyme-linked immunosorbent assay for the determination of human IgG subclass antibodies directed against Branhamella catarrhalis. J. Immunol. Methods 128:219-225.
21. Goldblatt, D., M. W. Turner, and R. J. Levinsky. 1990. Branhamella catarrhalis: antigenic determinants and the development of the IgG subclass response in childhood. J. Infect. Dis. 162:1128-1135.
22. Gulig, P. A., C. F. Frisch, and E. J. Hansen. 1983. A set of two monoclonal antibodies specific for the cell surface-exposed 39K major outer membrane protein of Haemophilus influenzae type b defines all strains of this pathogen. Infect, Immun. 42:516-524.
23. Gulig, P. A., G. H. McCracken, Jr., C. F. Frisch, K. H. Johnston, and E. J. Hansen. 1982. Antibody response of infants to cell surface-exposed outer membrane proteins of Haemophilus influenzae type b after systemic Haemophilus disease. Infect, Immun. 37:82-88.
24. Haase, E. M., K. Yi, G. D. Morse, and T. F. Murphy. 1994. Mapping of bacterial epitopes on the P2 porin protein of nontypeablc Haemophilus influenzae. Infect. Immun. 62:3712-3722.
25. Hager, H., A. Verghese, S. Alvarez, and S. L. Berk. 1987. Branhamella catarrhalis respiratory infections. Rev. Infect. Dis. 9:1140-1149.
26. Helminen, M. E., R. Beach, I. Maciver, G. P. Jarosik, E. J. Hansen, and M. Leinonen. 1995, Human immune response against outer membrane proteins of Moraxella (Branhamella) catarrhalis determined by immunoblotting and enzyme immunoassay. Clin. Diagn. Lab. Immunol. 2:35-39.
27. Helminen, M. E., I. Maciver, J. L. Latimer, L. D. Cope, G. H. McCracken, Jr., and E. J. Hansen. 1993. A major outer membrane protein of Moraxella catarrhalis is a target for antibodies that enhance pulmonary clearance of the pathogen in an animal model. Infect. Immun. 61:2003-2010.
28. Helminen, M. E., I. Maciver, J. L. Latimer, J. Klesney-Tait, L. D. Cope, M. M. Paris, G. H. McCracken, Jr., and E. J. Hansen. 1994. A large, antigenically conserved protein on the surface of Moraxella catarrhalis is a target for protective antibodies, J. Infect. Dis. 170:867-872.
29. Helminen, M. E., I. Maciver, J. L. Latimer, S. R. Lumbley, L. D. Cope, G. H. McCracken, Jr., and E. J. Hansen. 1993. A mutation affecting expression of a major outer membrane protein of Moraxella catarrhalis alters serum resistance and survival of this organism in vivo. J. Infect. Dis. 168:1194-1201.
30. Hsiao, C. B., S. Sethi, and T. F. Murphy. 1995. Outer membrane protein CD of Branhameua catarrhalis-sequence conservation in stains recovered from the human respiratory tract. Microb. Pathog. 19:215-225.
31. Kabat, E. A. 1970. Heterogeneity and structure of antibody-combining sites. Ann. N. Y. Acad. Sci. 169:43-54.
32. Kyte, J., and R. F. Doolittle. 1982. A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 157:105-132.
33. Maciver, I., M. Unhanand, G. H. McCracken, Jr., and E. J. Hansen. 1993. Effect of immunization on pulmonary clearance of Moraxella catarrhalis in an animal model. J. Infect. Dis. 168:469-472.
34. Malkamaki, M., E. Honkanen, M. Leinonen, and P. H. Makela. 1983. Branhamella catarrhalis as a cause of bacteremic pneumonia. Scand. J. Infect. Dis. 15:125-126.
35. McLeod, D. T., F. Ahmad, S. Capewell, M. J. Croughan, M. A. Calder, and A. Seaton. 1986. Increase in bronchopulmonary infection due to Branhamella catarrhalis. Br. Med. J. Clin. Res. 292:1103-1105.
36. Murphy, T. F., and L. C. Barlos. 1989. Surface exposed and antigenically conserved determinants of outer membrane proteins of Branhamella catarrhalis. Infect. Immun. 57:2938-2941.
37. Murphy, T. F., C. Kirkham, and A. J. Lesse. 1993. The major heat-modifiable outer membrane protein CD is highly conserved among strains of Branhamella catarrhalis. Mol. Microbiol. 10:87-97.
38. Murphy, T. F., and M. R. Loeb. 1989. Isolation of the outer membrane of Branhameua catarrhalis. Microb. Pathog. 6:159-174.
39. Nicotra, B., M. Rivera, J. I. Liman, and R. J. Wallace. 1986. Branhamella catarrhalis as a lower respiratory tract pathogen in patients with chronic lung disease. Arch. Intern. Med. 146:890-893.
40. Pettersson, A., B. Kuipers, M. Pelzer, E. Verhagen, R. H. Tiesjema, J. Tommassen, and J. T. Poolman. 1990. Monoclonal antibodies against the 70-kilodalton iron-regulated protein of Neisseria meningitidis are bactericidal and strain specific. Infect. Immun. 58:3036-3041.
41. Pettersson, A., A. Maas, D. van Wassenaar, P. van der Ley, and J. Tommassen. 1995. Molecular cloning of FrpB, the 70-kilodalton iron-regulated outer membrane protein of Neisseria meningitidis. Infect. Immun. 63:4181-4184.
42. Post, J. C., R. A. Preston, J. J. Aul, M. Larkins-Pettigrew, J. Rydquist-White, K. W. Anderson, R. M. Wadowsky, D. R. Reagan, E. S. Walker, L. A. Kingsley, A. E. Magit, and G. D. Ehrlich. 1995. Molecular analysis of bacterial pathogens in otitis media with effusion. JAMA 273:1598-1604.
43. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press. Cold Spring Harbor, N.Y.
44. Schechter, I. 1971. Mapping of the combined sites of antibodies specific to polyalanine chains. Ann. N. Y. Acad. Sci. 190:394-419.
45. Sethi, S., S. L. Hill, and T. F. Murphy. 1995. Serum antibodies to outer membrane proteins (OMPs) of Moraxella (Branhamella) catarrhalis in patients with bronchiectasis: identification of OMP B1 as an important antigen. Infect. Immun. 63:1516-1520.
46. Vaneechoutte, M., G. Verschraegen, G. Claeys, and A. M. van den Abeele. 1990. Respiratory tract carrier rates of Moraxella (Branhamella) catarrhalis in adults and children and interpretation of the isolation of M. catarrhalis from sputum. J. Clin. Microbiol. 28:2674-2680.
47. Yang, Y.-P., L. E. Myers, U. Mcguinness, P. Chong, Y. Kwok, M. H. Klein, and R. E. Harkness. 1997. The major outer membrane protein, CD, extracted from Moraxella (Branhamella) catarrhalis is a potential vaccine antigen that induces bactericidal antibodies. FEMS Immunol. Med. Microbiol. 17:187-199.
48. Yi, K., and T. F. Murphy, 1994. Mapping of a strain-specific bacterial epitope to the surface-exposed loop 5 on the P2 porin protein of non-typeable Haemophilus influenzas. Microb. Pathog. 17:277-282.